BNP Paribas Exane Cuts Clorox (NYSE:CLX) Price Target to $101.00

Clorox (NYSE:CLX) had its price objective lowered by equities researchers at BNP Paribas Exane from $103.00 to $101.00 in a report released on Friday,MarketScreener reports. The firm currently has an “underperform” rating on the stock. BNP Paribas Exane’s price target would suggest a potential downside of 8.14% from the stock’s previous close.

Other equities research analysts also recently issued reports about the stock. TD Cowen lowered their price objective on shares of Clorox from $117.00 to $108.00 and set a “hold” rating for the company in a research note on Thursday, January 8th. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $120.00 to $114.00 and set a “neutral” rating on the stock in a report on Friday. Citigroup reduced their target price on Clorox from $120.00 to $109.00 and set a “neutral” rating for the company in a research report on Wednesday, December 17th. Bank of America cut their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Finally, Rothschild & Co Redburn dropped their price target on Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. One investment analyst has rated the stock with a Buy rating, fourteen have given a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, Clorox currently has an average rating of “Reduce” and a consensus target price of $122.19.

Clorox Stock Performance

Shares of NYSE:CLX opened at $109.95 on Friday. The business has a 50-day moving average of $103.13 and a two-hundred day moving average of $115.32. The firm has a market capitalization of $13.41 billion, a PE ratio of 17.26, a P/E/G ratio of 0.55 and a beta of 0.58. Clorox has a 12 month low of $96.66 and a 12 month high of $164.22. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a net margin of 11.68% and a return on equity of 358.39%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter last year, the company posted $1.86 earnings per share. Clorox’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, research analysts forecast that Clorox will post 7.15 earnings per share for the current year.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the purchase, the director owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

Institutional investors have recently added to or reduced their stakes in the company. Center for Financial Planning Inc. acquired a new stake in shares of Clorox in the third quarter valued at approximately $25,000. Vermillion & White Wealth Management Group LLC bought a new position in shares of Clorox in the 3rd quarter worth $25,000. Total Investment Management Inc. purchased a new stake in Clorox during the 2nd quarter valued at about $25,000. American National Bank & Trust lifted its holdings in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares during the last quarter. Finally, True Wealth Design LLC lifted its holdings in Clorox by 1,020.0% in the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.